Skip to main content
Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery 4/2022

01.10.2021 | Original Article

A New Biomarker in Differentiation of Mucosal Chronic Otitis Media from Squamous Chronic Otitis Media: The Systemic Immune-Inflammation Index (SII)

verfasst von: Erkan Yıldız, Selçuk Kuzu, Çağlar Günebakan, Aydın Balcı

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

The Systemic Immune-inflammation Index (SII) is a new biomarker based on the number of neutrophils, platelets, and lymphocytes in the Complete blood count, and is shown as diagnostic and prognostic in many diseases. Mucosal or Squamous COM differentiation is necessary preoperatively in chronic otitis media patients. The purpose of this study was to test the predictive value of inflammation markers to predict the differentiation of Mucosal COM and Squamous COM. Our aim is; using "SII" as a powerful test to differentiate cholesteatoma and active mucosal middle ear disease. In the present study, 300 patients who underwent mastoidectomy ± tympanoplasty between 2010 and 2020 were retrospectively evaluated. The patients were divided into two equal groups as clinical, microscopically, and pathologically Squamosal COM (Cholesteatoma) and Mucosal COM (Suppurative) (n = 150). Routine hemogram tests were performed for both groups. White blood cell, red blood cell, neutrophil, lymphocyte, and platelet numbers were calculated. The SII value was calculated manually according to the formula of “neutrophil × platelet/lymphocyte. There were a total of 300 patients who were aged 20–63 in both groups. A total of 130 of these patients were male (43%), and 170 (57%) were female. In terms of NLR and PLR, Group 2 (Mucosal COM) had higher values at statistically significant levels (p < 0.001, p < 0.001, respectively). In terms of SII, Group 2 (Mucosal COM) had higher values at statistically significant levels (p < 0.001). According to the results of the ROC Analysis in our series, it was found that NLR, PLR, and SII values were above the acceptable level, and were statistically significant (p < 0.001, p < 0.001, p < 0.001, respectively). The cut-off value of SII was 470.29, sensitivity was 65.8, and specificity was 34. According to our study, high SII values in COM differentiation are very important in diagnosing Mucosal COM. SII values can help to the diagnosis in Squamous COM/Mucosal COM differentiation. There is no current practical, inexpensive, and widespread laboratory test used in the Mucosal/Squamous COM differentiation. SII can be diagnostic, and determine the treatment in this differentiation. A great number of studies are needed for SII values to become standard in COM.
Literatur
2.
Zurück zum Zitat Wallis S, Atkinson H, Coatesworth AP (2015) Chronic otitis media. Postgrad Med 127:391–395CrossRef Wallis S, Atkinson H, Coatesworth AP (2015) Chronic otitis media. Postgrad Med 127:391–395CrossRef
3.
Zurück zum Zitat Shirai N, Preciado D (2019) Otitis media: what is new? Curr Opin Otolaryngol Head Neck Surg 27:495–498CrossRef Shirai N, Preciado D (2019) Otitis media: what is new? Curr Opin Otolaryngol Head Neck Surg 27:495–498CrossRef
6.
Zurück zum Zitat Xie S, Xiang Y, Wang X et al (2016) Acquired cholesteatoma epithelial hyperproliferation: roles of cell proliferation signal pathways. Laryngoscope 126:1923–1930CrossRef Xie S, Xiang Y, Wang X et al (2016) Acquired cholesteatoma epithelial hyperproliferation: roles of cell proliferation signal pathways. Laryngoscope 126:1923–1930CrossRef
12.
Zurück zum Zitat Oya R, Takenaka Y, Imai T et al (2019) Neutrophil-to-lymphocyte ratio and platelet- to-lymphocyte ratio as prognostic hematologic markers of Bell’s palsy: a meta-analysis. Otol Neurotol 40:681–687CrossRef Oya R, Takenaka Y, Imai T et al (2019) Neutrophil-to-lymphocyte ratio and platelet- to-lymphocyte ratio as prognostic hematologic markers of Bell’s palsy: a meta-analysis. Otol Neurotol 40:681–687CrossRef
16.
Zurück zum Zitat Bakshi SS (2018) Neutrophil-lymphocyte and platelet-lymphocyte ratio for the effusion viscosity in Otitis Media. J Craniofac Surg 29:e98CrossRef Bakshi SS (2018) Neutrophil-lymphocyte and platelet-lymphocyte ratio for the effusion viscosity in Otitis Media. J Craniofac Surg 29:e98CrossRef
Metadaten
Titel
A New Biomarker in Differentiation of Mucosal Chronic Otitis Media from Squamous Chronic Otitis Media: The Systemic Immune-Inflammation Index (SII)
verfasst von
Erkan Yıldız
Selçuk Kuzu
Çağlar Günebakan
Aydın Balcı
Publikationsdatum
01.10.2021
Verlag
Springer India
Erschienen in
Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe 4/2022
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-021-02857-6

Weitere Artikel der Ausgabe 4/2022

Indian Journal of Otolaryngology and Head & Neck Surgery 4/2022 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.